Canadian Dollar Weakens Amid Falling Oil Prices

The Canadian dollar fell against its major counterparts in the European session on Friday, as oil prices dropped on concerns about the U.S. Federal Reserve's tightening path and a slowdown in the economic growth.

Crude for January delivery dropped $3.59 to 86.19 per barrel.

St Louis Fed President James Bullard said that the central bank will be required to continue raising interest rates by at least another full percentage point as the impact of tightening is having a limited effect so far.

Minneapolis Fed President Neel Kashkari said that the U.S. central bank shouldn't pause on monetary tightening before there is a clear indication that inflation has peaked.

Hawkish comments from Fed officials fuelled expectations for further interest rate rises that could derail the economic growth.

The loonie dropped to 0.8978 against the aussie and 1.3399 against the greenback, from its early highs of 0.8893 and 1.3300, respectively. The next possible support for the loonie is seen around the 0.90 against the aussie and 1.35 against the greenback.

The loonie was down at a 2-day low of 1.3865 against the euro. The loonie is poised to challenge support around the 1.40 mark.

The loonie slipped to 104.36 against the yen, from a 2-day high of 105.42 seen at 7:05 pm ET. The currency is likely to challenge support around the 103.00 region.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Consumer Product Safety Commission or CPSC announced recall of thousands of children's Robes made in China and sold exclusively on Amazon.com by various companies. The recalled robes fail to meet the federal flammability standards for children's sleepwear, posing a risk of burn injuries to children. Further, citing the same concerns, Paper Cape children's pajamas manufactured in Peru ... Health services company Cigna Corp. reported Friday higher profit in its fourth quarter reflecting growth in both Evernorth and Cigna Healthcare segments. Adjusted earnings and topline beat market estimates. Looking ahead for fiscal 2023, the company projects adjusted earnings and adjusted revenues to be higher than last year, but below market view. French drug major Sanofi SA reported Friday higher profit in its fourth quarter with strong revenue growth mainly with strong sales of Dupixent. Looking ahead for fiscal 2023, the company projects higher business earnings, but the expected growth is slower than recorded in fiscal 2022. Sanofi shares were losing around 4 percent in the morning trading in Paris as well as in pre-market activity...
Follow RTT